Search results (67)
« Back to NewsOxford spin-out raises $90 million to advance new treatments for blood cancers
5 Nov, 2026
Alethio Therapeutics, a University of Oxford spin-out co-founded by Professors Adam Mead and Beth Psaila, has secured $90 million (£67 million) in oversubscribed Series A financing to develop a new generation of therapies for myeloproliferative neoplasms (MPNs).
New technology helps decode the genetic changes behind disease
7 Oct, 2026
RDM researchers have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.
Everyday DNA damage reveals a hidden weakness in some cancers
28 Sep, 2026
Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.
Professor Marella de Bruijn receives MRC Programme Award
11 Sep, 2026
Congratulation to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.
Professor KJ Patel awarded Royal Society Buchanan Medal
27 Aug, 2026
Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.
New personalised therapy targets chronic blood cancer
2 Jul, 2026
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.
Professor KJ Patel awarded major European Research Council Advanced Grant
23 Jun, 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
Study reveals blood stem cells can ‘remember’ inflammation
27 May, 2026
Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers
Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
19 May, 2026
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.
Verena Korber receives CRUK Career Development Fellowship
1 Apr, 2026
Congratulations to Dr Verena Korber, who has been awarded a Career Development Fellowship from Cancer Research UK.
DNA-damaging formaldehyde accelerates blood ageing by extinction of stem cells
23 Mar, 2026
Researchers from the University of Oxford, the German Cancer Research Center, and Hospital Saint-Louis have uncovered a surprising new way that blood stem cells are lost over time, offering fresh insight into ageing and diseases that affect blood production.
New study reveals how blood cell production responds to parasite infection
11 Mar, 2026
Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.
Paresh Vyas receives CRUK Discovery Programme Award
11 Mar, 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
New bone marrow model offers scalable platform for next-generation drug discovery
24 Feb, 2026
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long term blood and immune cell production in a fully human 3D system.
Sarah Gooding and Rubeta Matin named NIHR Oxford Senior Research Fellows
19 Jan, 2026
Congratulations to Dr Sarah Gooding and Dr Rubeta Matin who have been appointed as the next cohort of NIHR Oxford BRC Senior Research Fellows.
Holly Russell receives Lee Placito Research Fellowship
9 Dec, 2025
Congratulations to Holly Russell who has been awarded a fellowship from the Lee Placito Medical Fund.
Study reveals how drug resistance develops early in targeted AML therapy
17 Nov, 2025
A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.
Oxford scientists capture genome’s structure in unprecedented detail
5 Nov, 2025
RDM scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.
Abdullah Khan receives Wellcome Career Development Award
4 Nov, 2025
Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.
Body-in-a-chip approach reveals how immune cells respond to heart injury
11 Sep, 2025
Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.